North America Cell Therapy Market to Grow at a CAGR of 7.4% to reach US$ 5,740.14 Million from 2020 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Cell Therapy Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Cell Therapy Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increase in Demand for Novel Therapeutics to Treat Chronic Diseases Like Cancer

5.2 Market Opportunities

5.2.1 Research and Development Funding

5.3 Future Trends

5.3.1 Technological Advancement

5.4 Impact of Drivers and Restraints

6. North America Cell Therapy Market Regional Analysis

6.1 North America Cell Therapy Market Overview

6.2 North America Cell Therapy Market Revenue 2017-2027 (US$ Million)

6.3 North America Cell Therapy Market Forecast Analysis

7. North America Cell Therapy Market Analysis – by Therapy Type

7.1 Allogeneic and Autologous

7.1.1 Overview
7.1.2 Allogeneic and Autologous: North America Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Cell Therapy Market Analysis – by Product

8.1 Consumables

8.1.1 Overview
8.1.2 Consumables: North America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Equipment

8.2.1 Overview
8.2.2 Equipment: North America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Systems and Software

8.3.1 Overview
8.3.2 Systems and Software: North America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

9. North America Cell Therapy Market Analysis – by Technology

9.1 Viral Vector Technology

9.1.1 Overview
9.1.2 Systems and Software: North America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Genome Editing Technology

9.2.1 Overview
9.2.2 Systems and Software: North America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

9.3 Somatic Cell Technology

9.3.1 Overview
9.3.2 Systems and Software: North America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Cell Immortalization Technology

9.4.1 Overview
9.4.2 Systems and Software: North America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Cell Plasticity Technology

9.5.1 Overview
9.5.2 Systems and Software: North America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

9.6 Three-Dimensional Technology

9.6.1 Overview
9.6.2 Systems and Software: North America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

10. North America Cell Therapy Market – North America Analysis

10.1 North America

10.1.1 North America Cell Therapy Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 North America Cell Therapy Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 US: North America Cell Therapy Market Breakdown, by Therapy Type
10.1.1.1.2 US: North America Cell Therapy Market Breakdown, by Product
10.1.1.1.3 US: North America Cell Therapy Market Breakdown, by Technology

10.1.1.2 Canada: North America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Canada: North America Cell Therapy Market Breakdown, by Therapy Type
10.1.1.2.2 Canada: North America Cell Therapy Market Breakdown, by Product
10.1.1.2.3 Canada: North America Cell Therapy Market Breakdown, by Technology

10.1.1.3 Mexico : North America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 Mexico : North America Cell Therapy Market Breakdown, by Therapy Type
10.1.1.3.2 Mexico : North America Cell Therapy Market Breakdown, by Product
10.1.1.3.3 Mexico : North America Cell Therapy Market Breakdown, by Technology

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Cell Therapy Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Vericel Corporation

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 MEDIPOST

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 NuVasive, Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Mesoblast Limited

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Smith & Nephew

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Bristol-Myers Squibb Company

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Stemedica Cell Technologies, Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Castle Creek Biosciences, Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights